TITLE:
Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease

CONDITION:
Alzheimer's Disease

INTERVENTION:
rivastigmine transdermal patch

SUMMARY:

      The goal of this research study is to evaluate the safety and efficacy of the rivastigmine
      transdermal patch in patients with probable Alzheimer's Disease.
    

DETAILED DESCRIPTION:
NONE

ELIGIBILITY:
Gender: All
Age: 50 Years to 85 Years
Criteria:

        Inclusion Criteria:

          -  Diagnosis of dementia of the Alzheimer's type

          -  Males, and females who are surgically sterile or one year postmenopausal

          -  A primary caregiver willing to accept responsibility for supervising the treatment

        Exclusion Criteria:

          -  Any condition (other than Alzheimer's) that could explain patient's dementia

          -  An advanced, severe or unstable disease that may put the patient at special risk

          -  Current diagnosis of active, uncontrolled seizure disorder or unstable cardiovascular
             disease
      
